Which of the following statements about tolterodine is true?
A. Tolterodine is only available in an extended-release formulation. B. The drug does not require any dosage adjustments for hepatic dysfunction C. It does not require any dosage adjustments for renal dysfunction D. Tolterodine has been found in clinical trials to a have a lower incidence of dry mouth compared with oxybutynin. • Tamsulosin is effective for the treatment of overflow incontinence by: A. Agonism of the alpha receptors to increase urethral sphincter tone. B. Antagonism at the alpha receptor, resulting in relaxation of the smooth muscles of the bladder neck and prostate. C. Antagonism at the muscarinic receptor to suppress detrusor contractions. D. Increasing the vascularity and thickness of the urethra. • Overflow incontinence is characterized by: A. Bladder overactivity. B. Bladder underactivity. C. Detrusor instability. D. Urethral hypermobility. • When receiving potent CYP3A4 inhibitors such as azole antifungals, dosage reductions are recommended for all of the followin
